B.A. Payer

2.1k total citations
42 papers, 1.6k citations indexed

About

B.A. Payer is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, B.A. Payer has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 34 papers in Hepatology and 8 papers in Infectious Diseases. Recurrent topics in B.A. Payer's work include Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (23 papers) and Liver Disease and Transplantation (15 papers). B.A. Payer is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (23 papers) and Liver Disease and Transplantation (15 papers). B.A. Payer collaborates with scholars based in Austria, Germany and United States. B.A. Payer's co-authors include Markus Peck‐Radosavljevic, Thomas Reiberger, Arnulf Ferlitsch, Michael Trauner, Philipp Schwabl, Mattias Mandorfer, Birgit Heinisch, Matthias Pinter, Petra Salzl and Armin Rieger and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

B.A. Payer

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.A. Payer Austria 22 1.4k 1.4k 412 135 90 42 1.6k
Vasiliki Arvaniti United Kingdom 9 1.1k 0.8× 1.1k 0.8× 391 0.9× 109 0.8× 156 1.7× 9 1.4k
Rubén Terg Argentina 22 1.1k 0.8× 984 0.7× 498 1.2× 72 0.5× 146 1.6× 58 1.5k
Jau‐Min Lien Taiwan 16 752 0.5× 630 0.5× 323 0.8× 128 0.9× 74 0.8× 31 1.2k
Juan Rodés Spain 15 1.2k 0.9× 1.0k 0.7× 604 1.5× 66 0.5× 67 0.7× 19 1.4k
David Bernstein United States 20 1.1k 0.8× 1.0k 0.7× 251 0.6× 348 2.6× 154 1.7× 50 1.6k
John Goulis Greece 21 1.8k 1.2× 1.7k 1.2× 700 1.7× 49 0.4× 94 1.0× 49 2.1k
Rami Moucari France 26 2.6k 1.9× 2.5k 1.8× 234 0.6× 184 1.4× 125 1.4× 49 2.9k
Hemda Schmilovitz‐Weiss Israel 17 805 0.6× 796 0.6× 276 0.7× 70 0.5× 25 0.3× 57 1.3k
Enric Reverter Spain 20 1.7k 1.2× 1.6k 1.1× 725 1.8× 56 0.4× 183 2.0× 50 1.9k
Dharmesh Kapoor India 15 812 0.6× 710 0.5× 313 0.8× 77 0.6× 56 0.6× 47 1.0k

Countries citing papers authored by B.A. Payer

Since Specialization
Citations

This map shows the geographic impact of B.A. Payer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.A. Payer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.A. Payer more than expected).

Fields of papers citing papers by B.A. Payer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.A. Payer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.A. Payer. The network helps show where B.A. Payer may publish in the future.

Co-authorship network of co-authors of B.A. Payer

This figure shows the co-authorship network connecting the top 25 collaborators of B.A. Payer. A scholar is included among the top collaborators of B.A. Payer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.A. Payer. B.A. Payer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Handisurya, Ammon, Andrea Tura, Harald Herkner, et al.. (2016). Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. PLoS ONE. 11(1). e0145319–e0145319. 4 indexed citations
2.
Mandorfer, Mattias, Philipp Schwabl, B.A. Payer, et al.. (2015). Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure. Wiener klinische Wochenschrift. 128(11-12). 414–420. 1 indexed citations
3.
Scheiner, Bernhard, Mattias Mandorfer, Philipp Schwabl, et al.. (2015). The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection. PLoS ONE. 10(11). e0143429–e0143429. 23 indexed citations
4.
Mandorfer, Mattias, B.A. Payer, Maximilian C. Aichelburg, et al.. (2014). Therapeutic Potential of and Treatment with Boceprevir/Telaprevir-Based Triple-Therapy in HIV/Chronic Hepatitis C Co-Infected Patients in a Real-World Setting. AIDS Patient Care and STDs. 28(5). 221–227. 8 indexed citations
5.
Schwabl, Philipp, B.A. Payer, Jelena Grahovac, et al.. (2014). Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats. Journal of Hepatology. 60(6). 1135–1142. 37 indexed citations
6.
Mandorfer, Mattias, Philipp Schwabl, B.A. Payer, et al.. (2014). Response-Guided Boceprevir-based Triple Therapy in HIV/HCV-coinfected Patients: The HIVCOBOC-RGT Study. The Journal of Infectious Diseases. 211(5). 729–735. 10 indexed citations
7.
Salzl, Petra, Thomas Reiberger, Monika Ferlitsch, et al.. (2014). Evaluation of Portal Hypertension and Varices by Acoustic Radiation Force Impulse Imaging of the Liver Compared to Transient Elastography and AST to Platelet Ratio Index. Ultraschall in der Medizin - European Journal of Ultrasound. 35(6). 528–533. 68 indexed citations
8.
Payer, B.A., Thomas Reiberger, Philipp Schwabl, et al.. (2013). 593 LENALIDOMIDE AMELIORATES THE PORTAL HYPERTENSIVE SYNDROME IN NON-CIRRHOTIC AND CIRRHOTIC PORTAL HYPERTENSIVE ANIMALS. Journal of Hepatology. 58. S242–S243. 1 indexed citations
9.
Mandorfer, Mattias, Karin Neukam, Thomas Reiberger, et al.. (2013). The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients. AIDS. 27(17). 2707–2714. 9 indexed citations
10.
Mandorfer, Mattias, B.A. Payer, Bernhard Scheiner, et al.. (2013). Health‐related quality of life and severity of fatigue in HIV/HCV co‐infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin. Liver International. 34(1). 69–77. 26 indexed citations
11.
Peck‐Radosavljevic, Markus, Bernhard Angermayr, Christian Datz, et al.. (2013). Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wiener klinische Wochenschrift. 125(7-8). 200–219. 44 indexed citations
12.
Beinhardt, S., B.A. Payer, Christian Datz, et al.. (2013). A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection. Journal of Hepatology. 59(5). 972–977. 21 indexed citations
13.
Mandorfer, Mattias, Thomas Reiberger, B.A. Payer, et al.. (2013). Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV‐/HCV‐coinfected patients: the role of metabolic factors and elevated GGT levels. Journal of Viral Hepatitis. 21(1). 33–41. 12 indexed citations
14.
Reiberger, Thomas, Gregor Ulbrich, Arnulf Ferlitsch, et al.. (2012). Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 62(11). 1634–1641. 228 indexed citations
15.
Ferlitsch, Monika, Thomas Reiberger, Matthias Hoke, et al.. (2012). Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Hepatology. 56(4). 1439–1447. 145 indexed citations
16.
Jaroszewicz, Jerzy, Thomas Reiberger, Dirk Meyer‐Olson, et al.. (2012). Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection. PLoS ONE. 7(8). e43143–e43143. 40 indexed citations
17.
Payer, B.A., Thomas Reiberger, F Breitenecker, et al.. (2012). The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV. Journal of Infection. 65(2). 142–149. 10 indexed citations
18.
Reiberger, Thomas, Arnulf Ferlitsch, B.A. Payer, et al.. (2012). Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience. Wiener klinische Wochenschrift. 124(11-12). 395–402. 93 indexed citations
19.
Reiberger, Thomas, Karoline Rutter, Arnulf Ferlitsch, et al.. (2011). Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection. Clinical Gastroenterology and Hepatology. 9(7). 602–608.e1. 49 indexed citations
20.
Payer, B.A., Thomas Reiberger, Karoline Rutter, et al.. (2010). Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV–HCV coinfected patient. Journal of Clinical Virology. 49(2). 131–133. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026